MAPT and supranuclear palsy, progressive, 1: FTLD-tau can be characterized by the predominance of 3R tau aggregates (Pick’s disease) or 4R tau pathology PSP, CBD, argyrophilic grain disease or globular glial tauopathy (GGT)5.